Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02

Among patients treated with the anticonvulsive and psychotropic drug carbamazepine (CBZ), approximately 10% develop severe and life-threatening adverse drug reactions. These immunological conditions are resolved upon withdrawal of the medicament, suggesting that the drug does not manifest in the bod...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Simper, Gwendolin S., Hò, Gia-Gia T., Celik, Alexander A., Huyton, Trevor, Kuhn, Joachim, Kunze-Schumacher, Heike, Blasczyk, Rainer, Bade-Döding, Christina
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6158965/
https://ncbi.nlm.nih.gov/pubmed/30302345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5086503
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars